Haemophilus influenzae type b

Details for Australian Patent Application No. 2006235045 (hide)

Owner The Institute for Genomic Research Novartis Vaccines and Diagnostics Inc.

Inventors Tettelin, Herve; Rappuoli, Rino; Masignani, Vega

Agent FB Rice

Pub. Number AU-A-2006235045

PCT Pub. Number WO2006/110413

Priority 60/667,921 30.03.05 US

Filing date 30 March 2006

Wipo publication date 19 October 2006

International Classifications

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/110413 Priority application(s): WO2006/110413

18 February 2010 Assignment before Grant

  Novartis Vaccines and Diagnostics Inc.; The Institute for Genomic Research The application has been assigned to Novartis Vaccines and Diagnostics Inc.; J. Craig Venter Institute ,Inc.

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006235054-Integration of gasification and ammonia production

2006235040-Compositions comprising a cocoa butter component and an animal-derived fat component